NERV Earnings Date: Nov 4, 2026 (Estimated) — Minerva Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is NERV's next earnings date?
Minerva Neurosciences, Inc. (NERV) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.14.
How did NERV do in its last earnings report?
In its most recent report on Aug 7, 2026 (Q2 2026), Minerva Neurosciences, Inc. posted EPS of -$0.10 versus the -$0.19 estimate, a beat of 890.0%. Revenue was $0. The stock's 1-day post-earnings move was -3.8%.
How much does NERV stock move after earnings?
NERV beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.2% (up or down) in the day after earnings.
About Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other neurodegenerative conditions. The company has a contractual licensing agreement with Mitsubishi Tanabe Pharma Corporation, authorizing the worldwide development, distribution, and import of roluperidone, with the explicit exclusion of the Asian continent. Established in 2007, this organization initially operated as Cyrenaic Pharmaceuticals, Inc. before undergoing a name change to Minerva Neurosciences, Inc. in 2013. Its corporate headquarters are located in Waltham, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Q2 2026 | -0.19 | -0.10 | -890.00% | $0 | ✅ Beat | -3.83% | -11.71% | -0.23% |
| 2026-05-05 | Q1 2026 | -0.13 | -0.17 | -30.77% | $0 | ❌ Miss | -1.26% | -11.06% | -26.07% |
| 2026-03-11 | Q4 2025 | -0.11 | -0.64 | -481.82% | $0 | ❌ Miss | -8.06% | -1.13% | -24.18% |
| 2025-11-05 | Q3 2025 | -0.35 | -0.36 | -2.86% | $0 | ❌ Miss | +4.09% | +8.17% | +1.91% |
| 2025-08-14 | Q2 2025 | -0.92 | -0.43 | +53.26% | $0 | ✅ Beat | +25.35% | +34.54% | +25.35% |
| 2025-02-25 | Q4 2024 | -1.05 | -0.56 | +46.67% | $0 | ✅ Beat | +0.00% | -14.53% | +3.35% |
| 2024-11-05 | Q3 2024 | -1.01 | 2.97 | +394.06% | $0 | ✅ Beat | +1.72% | +0.00% | -5.60% |
| 2024-08-06 | Q2 2024 | -0.97 | -1.09 | -12.37% | $0 | ❌ Miss | +5.00% | +2.14% | -6.43% |
Showing last 8 quarters.